Contact us : info@bioworlde.com
Home > Product > Antigen-Peptide
SLC22A2 Peptide BS60420P
Product NameSLC22A2 Peptide
Catalog No.BS60420P
ApplicationsBlocking
Swiss-ProtO15244
Product1 mg/ml in DI water.
Purification&PuritySynthetic peptide SLC22A2. (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&StabilityStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
SpecificityThis peptide can be used with studies using BS60420 SLC22A2 pAb.
Browse similar products>>
Size Price
1mg $368
Add to cart My orders
Product Name :
SLC22A2 Peptide
Applications :
Blocking
Background :
Organic cation transporters (OCT) are expressed in the plasma membrane of epithelial cells from a wide range of tissues, where they function in the elimination of endogenous amines, cationic drugs and other xenobiotics. The structure of OCTs consists of a 12-transmembrane-domain structure and a large extracellular hydrophilic loop. In humans, OCT1 is primarily expressed in the liver, while OCT2 is expressed in the kidney. OCT3 is expressed in the placenta, skeletal muscle, prostate, aorta and liver. OCT2, also known as SLC22A2, is a multi-specific transporter protein localizing to the basolateral and luminal membranes of the kidney distal tubule and proximal tubules. OCT2 is responsible for mediating the pH-sensitive tubular uptake of organic compounds from circulation. An additional splice variant exists for OCT2, namely OCT2-A.
Alternative Name :
Solute carrier family 22 member 2; Organic cation transporter 2; hOCT2; OCT2
Swiss-Prot :
O15244
Product :
1 mg/ml in DI water.
Purification&Purity :
Synthetic peptide SLC22A2. (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
This peptide can be used with studies using BS60420 SLC22A2 pAb.
Blocking peptide available as BS60420PP
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER